Neonatal sepsiste başlangıç antibiyotik tedavisinin belirlenmesi
Loading...
Files
Date
1982
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Uludağ Üniversitesi
Abstract
Uludağ Üniversitesi Tıp Fakültesi Çocuk Sağlığı ve Hastalıkları Kliniğinde kesin neonatal sepsis tanısı konan 55 olgudan elde edilen 62 kan kültürlerinde üretilen mikroorganizmaların antibiyogramları incelenmiştir. Çalışmaya alınan antibiyotiklerden en sık olarak cefazoline karşı duyarlılık saptanmış (% 27.4) ve bunu sırasıyla gentamicin (% 9.6), kanamycin (% 8.0) ve ampicillin (% 3.2) izlemi tir. Penicilline karşı duyarlı bakteri ürememiştir. Bu bulgulara dayanarak neonatal sepsis ön tanısı konulmasından sonra cefazolin + gentamicin kombinasyonunun başlanılması önerilmiştir.
Antibiograms of 62 blood cultures of 55 neonatal sepsis cases who were diagnosed and treated in Department of Pediatrics of Uludağ University Medical Faculty have been studied. The highest percentage of sensitivity was to cefazolin (% 27.4) which were followed by gentamicin (% 8.6), kanamycin (% 8.0) and ampicillin (% 3.2). There were no sensitivity to penicillin. From these findings it was recommended that cefazolin and gentamicin combination should the started for the initial treatment of neonatal sepsis.
Antibiograms of 62 blood cultures of 55 neonatal sepsis cases who were diagnosed and treated in Department of Pediatrics of Uludağ University Medical Faculty have been studied. The highest percentage of sensitivity was to cefazolin (% 27.4) which were followed by gentamicin (% 8.6), kanamycin (% 8.0) and ampicillin (% 3.2). There were no sensitivity to penicillin. From these findings it was recommended that cefazolin and gentamicin combination should the started for the initial treatment of neonatal sepsis.
Description
Keywords
Neonatal sepsis, Antibiyotik tedavisi, Antibacterial treatment, Antibiogram
Citation
Günay, Ü. ve Parıldar, T. (1982). "Neonatal sepsiste başlangıç antibiyotik tedavisinin belirlenmesi". Uludağ Üniversitesi Tıp Fakültesi Dergisi, 9(2-3), 115-119.